Introduction
The polyglutamine (polyQ) diseases represent an important cause of heritable neurodegeneration, comprising at least nine disorders (reviewed in Ref.
[1]; Table 1 ). All nine result from the expansion of a CAG repeat in the respective disease genes, encoding an abnormally long glutamine tract in the disease proteins. With one exception (the Xlinked disorder SBMA), CAG/polyQ repeat expansions are transmitted to successive generations in affected families through an autosomal dominant manner. In all nine diseases, including SBMA, CAG/polyQ expansions act in a dominant toxic manner to cause disease. This shared mutation suggests a common pathogenic mechanism among the polyQ diseases, notwithstanding the fact that the pathogenic proteins are evolutionarily and functionally unrelated.
A decade ago, a clue to pathogenesis came from the discovery that expanded polyQ proteins accumulate within intraneuronal inclusions in select brain regions. This observation, coupled with in vitro experiments modeling polyQ protein aggregation, quickly led to the hypothesis that polyQ protein aggregation, and perhaps the inclusion itself, mediated neurodegeneration. The appeal of this hypothesis stemmed partly from the mechanistic link it suggested to other, more common age-related neurodegenerative disorders in which aggregates of specific proteins accumulate, including Alzheimer's disease (AD) and Parkinson's disease (PD).
Subsequently, inclusions have fallen out of favor as a primary pathogenic entity. Many cell-based, animal model and human autopsy studies suggest that inclusions are simply the byproduct of abnormal protein accumulation or perhaps even a cytoprotective response that sequesters abnormal proteins [2] [3] [4] [5] . This has led to understandable confusion in the field about whether protein misfolding and aggregation are indeed central to disease pathogenesis. Recent studies using divergent approaches, however, now support the importance of protein misfolding in polyQ disease pathogenesis. Here we synthesize these findings into a broader understanding of the role played by protein misfolding in these intriguing neurodegenerative disorders, and place them in the larger context of age-related neurodegeneration.
Lots of trouble from one amino acid
PolyQ diseases fall within the larger category of protein conformational brain disorders. As with most age-related neurodegenerative disorders, polyQ diseases are characterized by amyloid-like deposits of the disease protein in the central nervous system (CNS). Expanded polyQ proteins are prone to aggregate and, the longer the expansion, the more robust the aggregation. Disease severity also correlates directly with the length of the expansion, measured both by the age of symptom onset and by the extent of CNS pathology: longer repeats lead to earlier onset and more widespread degeneration. With the most common sized expansions, disease typically does not manifest until well into adulthood despite expression of the mutant protein throughout life.
Despite their presumably shared disease mechanism, polyQ diseases differ clinically and neuropathologically. Although many are degenerative spinocerebellar ataxias, one is primarily a motor neuron disorder (SBMA), and another is characterized by striatal and cortical degeneration (Huntington's disease; HD). This preferential loss of specific neuronal populations occurs despite widespread expression of the disease proteins [6] . A closer look reveals that even the polyQ expansions differ somewhat among the
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Glossary
Amyloid: name given to proteins or peptides that have adopted a nonnative, bsheet-rich structure and aggregate in tissue. Amyloid structures assumed by diverse, unrelated proteins share common properties, including reactivity with thioflavin-S and Congo Red stains. Inclusion: an intracellular, frequently spherical accumulation of proteins in the nucleus or cytoplasm, visible by light microscopy with antibodies directed against polyQ disease protein or ubiquitin. Often contain proteins involved in the ubiquitin-proteasome and molecular chaperone systems. Microaggregates: detergent-resistant protein aggregates, much smaller than inclusions, that might or might not be pure homo-oligomers of disease protein.
Microaggregates are soluble in that they partition in the soluble fraction of brain lysates, but are not dissociable by denaturing detergent. 
